US$ 21.33
tirzepatide approved for teens Microdose Tirzepatide is a New Medication
Description
Appetite suppression continues effectively, but the nausea and gastrointestinal issues that plagued earlier weeks typically fade to minimal levels
The FDA approved tirzepatide for chronic weight management for adults with obesity or with overweight and one weight-related comorbidity in November
Maybe they simply ran out of the lower concentration

Health Canada has approved 6 medications for long-term obesity management: liraglutide (Saxenda), naltrexonebupropion (Contrave), orlistat (Xenical), semaglutide (Wegovy), tirzepatide (Zepbound), and setmelanotide (Imcivree)
